Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gower Publishing

- PMLiVE

Porterhouse Insights expands its senior team following a year of significant growth.

Porterhouse Medical Group is delighted to welcome David Eatwell, who joins the team at Porterhouse Insights as Director.David, an experienced and innovative pharma insight professional, will bolster the expertise and...

Porterhouse Medical Group

- PMLiVE

UK vaccinations top nine million as concerns rise over South Africa variant

Surge testing is set to take place in eight areas linked to variant

- PMLiVE

Horizon bolsters rare disease portfolio with $3bn Viela Bio acquisition

Viela's portfolio of assets includes FDA-approved NMOSD therapy Uplizna

regeneron headquarters

EMA launches rolling review of Regeneron’s COVID-19 antibody cocktail

Study suggests REGN-COV2 can reduce viral load in non-hospitalised patients with COVID-19

Ashfield Healthcare Communications rebrands as Ashfield Health

Ashfield Health, part of UDG Healthcare plc, announces transformational changes including the unveiling of a new Global President, a rebrand, and the launch of two new global agencies.

Inizio

- PMLiVE

Transforming clinical trial data into a long-term asset

Considering the future of the trial master file in the light of COVID-19 and accelerated digital transformation

A MERGER THAT MATTERS

Pegasus, Ashfield Digital and Creative and Cambridge Biomarketing relaunch as Mind+Matter     ‘First-in-class’ global agency conceived to confront the toughest challenges in healthcare and wellness   New global agency offers 24/7 access...

Inizio

- PMLiVE

UK orders 40 million additional doses of Valneva’s COVID-19 vaccine

The UK's vaccine portfolio now includes a total of 407 million doses from a number of companies

- PMLiVE

Well-funded life sciences firms are making long-term progress – and their investors are too

This is an exciting time for British biotech and pharma, as the intense efforts to find a solution to COVID-19 offer a way out of the pandemic

- PMLiVE

CHMP recommends EU approval for Amarin’s cardiovascular risk reduction drug

The drug is recommended for use in adult patients who are already receiving statin treatment

- PMLiVE

Q&A: Louise Sharp

PME interviews Makara Health's owner and managing director

- PMLiVE

Novartis, Bayer announce separate agreements to bolster COVID-19 vaccine manufacturing

Novartis will help manufacture Pfizer/BioNTech's vaccine and Bayer will do the same for CureVac's vaccine

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links